Q32 Bio Inc. (QTTB) Free cash flow 2017–2025
Q32 Bio Inc. (QTTB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$33.5MFY2025 · since FY2017: $4.5M → -$33.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.5M | +50.5% |
| FY2024 | -$67.8M | -262.9% |
| FY2023 | -$18.7M | +83.7% |
| FY2022 | -$114.9M | -2.5% |
| FY2021 | -$112.1M | -14.4% |
| FY2020 | -$98.1M | +13.4% |
| FY2019 | -$113.2M | -67.7% |
| FY2018 | -$67.5M | -1593.1% |
| FY2017 | $4.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More QTTB financial trends
QTTB RevenueQTTB Net incomeQTTB Net marginQTTB Gross profitQTTB Gross marginQTTB Operating incomeQTTB Operating marginQTTB Operating cash flowQTTB Capital expendituresQTTB Return on equityQTTB Stock buybacksQTTB Dividends paidQTTB Total assetsQTTB Total liabilitiesQTTB Shareholders’ equityQTTB overview →